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Abstract 
Objective: Despite a growing call to use patient-reported outcomes (PRO) in clinical 
research, few are available for measuring upper limb function post-stroke. We examined the 
Disabilities of the Arm, Shoulder and Hand (DASH) to evaluate its measurement 
performance in acute stroke. In doing so, we compared results from traditional and modern 
psychometric methods. 
 
Methods: 172 people with acute stroke completed the DASH. Those with upper limb 
impairments completed the DASH again at 6 weeks (n=99). Data (n=271) were analysed 
using two psychometric paradigms: traditional psychometric (Classical Test Theory, CTT) 
analyses examined data completeness, scaling assumptions, targeting, reliability and 
responsiveness; Rasch Measurement Theory (RMT) analyses examined scale-to-sample 
targeting, scale performance and person measurement. 
 
Results: CTT analyses implied the DASH was reliable and valid in this sample. Data 
completeness was high, criteria for scaling assumptions were satisfied (item-total correlations 
0.55-0.95), targeting was good, internal consistency reliability was high (Cronbach’s alpha = 
0.99), and responsiveness was clinically moderate (effect size = 0.51). However, RMT 
analyses identified important limitations: scale-to-sample targeting was suboptimal, four 
items had disordered response category thresholds, sixteen items exhibited misfit, three pairs 
of items had high residual correlations (>0.60), and 84 person fit residuals exceeded the 
recommended range.  
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Conclusions: RMT methods identified limitations missed by CTT and indicate areas for 
improvement of the DASH as an upper limb measure for acute stroke. Findings, similar to 
those identified in multiple sclerosis, highlight the need for scales to have strong conceptual 
underpinnings, with their development and modification guided by sophisticated 
psychometric methods.  
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INTRODUCTION 
Approximately 70-80% of people with acute stroke have upper limb dysfunction.[1, 2] This 
can affect a person’s ability to perform activities of daily living (ADLs), including self-care, 
leisure, work and social activities, and impacts on levels of independence.[3] Therefore, 
recovery of upper limb function is often a primary goal for rehabilitation following stroke.[4, 
5] It is commonly assessed using clinician-rated or performance outcome measures (ClinROs, 
PerFOs) including the Box and Block Test[6] and the Action Research Arm Test.[7] 
 
One goal of patient-reported outcome (PRO) measures is to quantify the activity and 
participation restrictions that arise from impairments in order to examine their impact on 
individuals’ daily lives and evaluate their treatments.[5, 8] However, despite a growing call to 
include PRO measures in clinical research including stroke,[9-11] few upper limb PRO 
measures have been used in acute stroke.[3, 5] 
 
The Disabilities of the Arm, Shoulder and Hand (DASH) is a PRO instrument purporting to 
measure physical function and symptoms in people with upper limb disorders.[12] Originally 
developed for use in orthopaedic populations,[12] it is one of the most widely used upper 
limb rating scales.[13, 14] Its psychometric properties have been extensively evaluated in 
musculoskeletal disorders;[3] however, there are no published psychometric evaluations of 
the DASH in stroke.[3, 15]  
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The widespread use of the DASH underpinned our evaluation in people with acute stroke to 
examine its suitability as an outcome measure. We used two psychometric paradigms: 
traditional psychometric methods based on Classical Test Theory (CTT)[16] and modern 
psychometric methods based on Rasch Measurement Theory (RMT).[17] There were two 
aims: to evaluate the measurement properties of the DASH in people with acute stroke; and, 
to compare and contrast CTT with RMT. 
 
METHODS 
Participants, recruitment and data collection 
This is a pooled sample of three subgroups of people in the early post-stroke period. People 
admitted to the Hyper-acute Stroke Unit (HASU) at the National Hospital for Neurology and 
Neurosurgery (NHNN) completed the DASH regardless of presence or extent of upper limb 
dysfunction as part of a routine battery of outcome measures (n=125). Other people with 
upper limb dysfunction were recruited from the Albany Rehabilitation Unit (ARU) at the 
NHNN (n=34) and the National Rehabilitation Unit (NRU) at the NHNN (n=13). Participants 
were between 48 hours and 12 weeks post-stroke, 18+ years of age, had an imaging-
confirmed diagnosis of stroke, were screened by a research nurse for suitability for inclusion 
in the study (including cognition and language/communication) and provided full informed 
consent. People unable to read or with difficulties understanding the questionnaire (due to 
severe cognitive or language/communication impairment) were excluded. The DASH was 
administered across all three units by a clinician (the first author) who provided instructions 
and support during completion. Ethical approval was obtained from the Joint Research Ethics 
Committee of the Institute of Neurology and the NHNN. 
 
PRO Instruments 
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The DASH has 30 items aiming to measure physical function and symptoms in people with 
upper limb disorders.[12] Items are scored from 1 (no difficulty) to 5 (unable), summed to 
generate a total ‘disability/symptom’ score, and averaged to produce a mean item score 
between 1 and 5. This value is transformed to a score out of 100 by subtracting one and 
multiplying by 25. A higher score indicates greater disability. 
 
Analysis Plans 
We used the approach some of us had taken in examining the DASH in multiple sclerosis 
(MS).[18] Specifically, we compared and contrasted psychometric evaluations using 
CTT[16] and RMT.[17] 
 
Traditional psychometric (CTT) methods 
CTT methods examined five psychometric properties of the DASH, the statistical methods 
and associated criteria are documented fully elsewhere.[18-26] Specifically and in brief, we 
examined DASH data against published criteria for: (1) data completeness (percent missing 
data for each item[21]); (2) scaling assumptions (similarity of item means and variances, 
magnitude and similarity of corrected item-total correlations[19-22]); (3) scale-to-sample 
targeting (score means, standard deviation (SD), floor and ceiling effects[23, 24]); (4) 
internal consistency reliability (Cronbach’s alpha;[25] mean inter-item correlation[26]); and 
(5) responsiveness, examined by comparing baseline and 6-week scores (effect size and 
standardized response mean). Data analyses were conducted using SPSS (version 19.0). 
 
Rasch Measurement Theory (RMT) methods 
In RMT, the degree to which measurements can be derived from item responses is evaluated 
using a single mathematical equation, the Rasch model, which defines how a set of items 
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should perform in order to generate reliable and valid measurements.[17, 27, 28] RMT is 
explained for clinicians elsewhere.[29] Briefly, RMT examines the extent to which the 
observed scores (person responses) ‘fit’ the expected values predicted by the Rasch model, 
indicating the degree to which rigorous measurement is achieved. RMT analyses were 
grouped into three areas: scale-to-sample targeting, scale performance and person 
measurement. The methods and associated criteria are documented fully elsewhere.[18, 27, 
29-32] Data analyses were conducted using RUMM2030.[33] 
 
RESULTS 
Sample 
The sample (n=172) included: 125 people admitted to the HASU, 34 people admitted to the 
ARU, and 13 people admitted to the NRU (Table 1). People with upper limb impairments, as 
identified from clinical assessment, completed the DASH 6 weeks later (n=99; 
Supplementary Table I). Therefore, data from 271 questionnaires were stacked for 
analysis.[29] At baseline, the sample mean age was 61 years (range 18-75), mean time post-
stroke was 3 weeks (range 1-12) and 41% were women (Table 1). 
 
Traditional psychometric (CTT) methods 
The results of CTT analyses supported the DASH as a reliable and valid measure of upper 
limb function in stroke. In summary, traditional psychometric criteria were satisfied for all 
measurement properties evaluated (data completeness, scaling assumptions, targeting, 
reliability, responsiveness; Table 2). 
 
Data completeness 
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Table 2 shows that data completeness was high: there were no item-level missing data, and 
scale scores were computable for all respondents.  
 
Scaling assumptions 
Criteria for scaling assumptions were satisfied: items had similar mean scores and variances, 
and all corrected item-total correlations exceeded 0.30 (Table 2).  
 
Targeting 
DASH scores spanned 88% of the scale range and were not notably skewed. There was no 
floor effect but a ceiling effect of 14.4%, below the recommended 20% maximum (Table 
2).[23, 24]   
 
Reliability 
Internal consistency reliability was very, perhaps surprisingly, high (Cronbach’s alpha=0.99) 
and the mean inter-item correlation (0.70) exceeded the recommended minimum of 0.30 
(Table 2). The 95% confidence interval around DASH scores was ±5.25 points. 
 
Responsiveness 
The mean change in scores for the subsample of people who completed the DASH again at 6 
weeks (n=99) was 12.4pts (SD 17.7; Table 2). This group-level improvement was statistically 
significant and clinically moderate according to Cohen’s criteria.[34] 
 
Rasch Measurement Theory (RMT) methods 
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RMT analyses were more informative than those from CTT. As some item response categories 
had not been endorsed we invoked the null category adjustment feature available in 
RUMM2030.[35] 
 
Scale-to-sample targeting 
Scale-to-sample targeting was suboptimal. Figure 1 shows that the sample appears reasonable 
for examining scale performance: the sample covers the item locations. However, the scale 
does not cover the sample: a number of people are not covered by the items and the ceiling 
effect is notable.  
 
Scale performance 
Did the item response categories work as intended? 
Thresholds were disordered for 4/30 items implying that the 5-category scoring function was 
not working as intended for these items (Table 4; Supplementary Figure I). For one item 
(‘write’), people appeared to have difficulty discriminating between the first three categories 
(Supplementary Figure IB). For three items (‘pain’, ‘pain performing an activity’, ‘tingling’), 
people appeared to have difficulty discriminating between the final three categories 
(Supplementary Figure IC).  
 
What continuum was mapped out by the items? 
Item locations ranged from −1.61 to +1.78 logits, item thresholds from −3.95 to +3.59 logits, 
indicating the items mapped out a measurement continuum (Table 3). However, there was 
limited spread and items were bunched at points along the continuum (Figure 1).  
 
To what extent did the items work together? 
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Sixteen items had fit residuals outside the recommended range (−2.5 to +2.5), one notably so 
(‘feeling less capable’, +12.39), and eight items had significant chi-square values (Table 4). 
Examinations of the graphical indictor of fit (ICC) showed that most items displayed 
reasonable visual fit despite statistical misfit. However, ICCs for three items suggested they 
were under-discriminating: ‘write’, ‘sexual activities’ and ‘feeling less capable’ 
(Supplementary Figure II). 
 
To what extent did the response to one item bias the response to another? 
Sixty-five pairs of items had residual correlations exceeding the criteria of <0.30 (15% of 
total correlations) implying that a response to one item influenced the response to the other 
item. Three pairs of items correlated highly (>0.60): ‘do heavy household chores’ with 
‘garden’ (0.63); ‘recreational activities: force/impact’ with ‘recreational activities: move arm 
freely’ (0.80); and ‘pain’ with ‘pain performing an activity’ (0.87).  
 
Person measurement 
Person measures covered a wide range (−6.65 to +2.90 logits) and the Person Separation 
Index (PSI=0.96) implied good sample separation and high reliability (Table 3). However, 84 
person fit residuals (range −5.85 to +5.00) exceeded the recommended range (−2.5 to +2.5) 
implying that approximately 36% of people gave responses not in keeping with expectation.  
Table 3 shows that group-level responsiveness analyses recorded a significant improvement 
at 6 weeks post-stroke, clinically mild-to-moderate according to Cohen’s criteria.[34] At the 
individual person level, 51% had a statistically significant improvement and a further 30% 
made a non-significant improvement.   
 
DISCUSSION 
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Our aim was to evaluate the measurement performance of the DASH in a sample of people 
early post-stroke. Traditional psychometric methods implied that the DASH was reliable and 
valid. Our findings were similar to our CTT examination of the DASH in MS[18] and 
supported the summing of item scores into a single upper limb symptom/disability score. 
However, RMT analysis provided more sophisticated information and raised concerns about 
the DASH as an outcome measure in acute stroke.  
 
RMT analyses revealed that, for four items, the scoring function did not work as intended.  
One explanation is that there are too many response categories for people to reliably choose 
between. This finding is consistent with our previous study in MS.[18] Another explanation 
arises from the sub-optimal targeting. For the pain items, there were not enough people 
located at the more disabled end of the continuum to infer confidently that threshold 
disordering exists. RMT analyses identify problems; they do not indicate the cause. Exploring 
possible reasons for the disordering is important as ordered thresholds are necessary for scale 
validity.[30, 36] 
 
Over 50% of items had statistical misfit implying that the items were not as statistically 
cohesive as required for deriving measurements from an item set. Item misfit has many 
possible causes, including disordered thresholds. However, misfit may arise from the content 
of the item set. The DASH has items measuring physical function, symptoms and social 
participation. Previously, we suggested the DASH is capturing a broader construct, not 
simply upper limb functioning.[18] From a measurement perspective, combining symptoms 
with functioning threatens scale validity. From a clinical perspective, this means that DASH 
scores lack meaning and interpretability. 
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The hierarchical ordering of the DASH items suggests, from a clinical perspective, that the 
scale items represent more than one dimension (multidimensionality). Examination of the 
item locations in Table 4 reveals that the item ordering is not intuitive clinically. We explored 
this further by combining the items into four clinically sensible groups – symptoms (items 
24-29), participation (items 17-23, 30), dexterity (items 1-4, 15, 16) and power/range of 
motion (items 5-14) – and performing exploratory subtest analyses. Subtest analyses are 
performed post-hoc and can be used to explore the presence of multidimensionality within a 
scale. Perhaps counterintuitively, traditional reliability indicators can be over-inflated by 
multidimensionality, in part because they are not indicators of unidimensionality as is 
mistakenly thought.[31] In a subtest analysis, items are grouped into ‘subtests’ which are then 
treated by the analysis as single ‘super’ items. So here, the four item groups or ‘subtests’ are 
analysed as if they were a four-item scale. If reliability indicators (e.g. PSI and alpha) fall, 
multidimensionality is implied. We found that the PSI dropped from 0.96 to 0.87 (alpha 
dropped from 0.99 to 0.92) implying that DASH reliability was artificially inflated, 
supporting our clinical impression of multidimensionality. However, this issue is not simple 
because a fall in reliability indicators following subtest analysis can also occur when there is 
item response bias (local dependence). Also, alpha values are dependent on the number of 
extreme scores (here a notable amount) and item-item correlations (here very high). We 
would stress that this issue is complex and a full discussion and examination beyond the 
scope of this manuscript, and refer interested readers to other sources.[31,32]  
 
As highlighted above, reliability indicators can also be inflated by local dependence among 
items, or item response bias.[31] We found 65 pairs of items with residual correlations >0.30 
and three pairs of items which correlated highly (>0.60) suggesting local dependency. All 
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three pairs of highly correlated items appear sequentially in the DASH and have similar 
content, implying that this dependency may be due to an ordering and/or content effect. 
 
Targeting is worthy of particular attention when a scale is being used outside its original 
context area, and sub-optimal targeting has important implications. An added advantage of 
RMT is the graphical targeting illustration: the match between item locations and person 
locations (Figure 1). Here, the measurement of people with mild upper limb dysfunction is 
limited, and the ceiling effect indicates that a notable proportion of people had no measured 
upper limb dysfunction post-stroke. Therefore, despite satisfying published criteria,[23,24] 
the ceiling effect represents a cohort of the sample for whom changes within people and 
differences between people will be underestimated.[37] This has implications for endpoint 
measurement and selection of outcome measures early post-stroke. 
 
When selecting endpoint measures, scales should be targeted to clinical settings as well as the 
sample. Therefore, an important consideration is the nature of the items in relation to the 
intended context of use. For example, sixteen DASH items concern activities of daily living 
(ADLs) which are potentially difficult for people to report meaningfully within acute settings. 
People may have guessed their abilities which could explain the high ability findings in a 
disorder where upper limb dysfunction is common. Guessing could also account for the high 
number of misfitting persons detected by RMT analyses compared to those found in MS 
(stroke=36%; MS=8%).[18] 
 
Cognitive impairment can affect performance of PROs, causing person misfit, and is an 
important factor to consider early post-stroke. We did not formally assess cognitive status; 
instead a clinical judgement was made on whether the person was suitable for inclusion or 
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not based on informal screening by a research nurse. We acknowledge this is a limitation but 
it is difficult to determine the exact cut-off score on a cognitive test which would indicate the 
point at which a person was able to give valid responses on a PRO. This area is complex and 
requires further investigation. Rasch measurement methods profile individual person 
response patterns which can allude to the presence of cognitive impairment, especially if 
responses are way out of keeping. However, despite notable levels of disability, person fit 
was better in MS (a condition in which cognition is affected) than in stroke (8% vs 36% 
misfit) as outlined above. This lends support to our suggestion that misfit may have been due 
to people guessing their abilities within a context where they were unable to perform many of 
the ADLs included in the DASH. 
 
Responsiveness analyses showed that the DASH recorded improvements in the subsample of 
people who had upper limb impairments (n=99; see Supplementary Table I for sample 
characteristics). RMT methods are able to go beyond CTT methods of group-level 
responsiveness testing and examine individual person-level change (Table 3). Our results are 
in keeping with clinical expectation of early post-stroke recovery. However, a proportion of 
people did get worse, some significantly. One explanation is that, during recovery, some 
people may have become more aware of their limitations and difficulties, and provided more 
accurate reporting at the 6-week follow-up. Further work is required to examine these 
individual’s responses and help explain anomalies.      
 
A limitation of this study is that the DASH was administered to patients admitted to the 
hyper-acute stroke unit regardless of whether any upper limb impairment existed or not. This 
is because a pre-determined battery of measures was administered. However, it highlights the 
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need for careful consideration of instrument selection and patient recruitment to ensure 
appropriate scales are targeted to appropriate people.  
 
A further limitation is that we did not undertake standard validity testing. However, 
correlations with other measures provide circumstantial validity evidence only and would 
have added little to our findings.[38, 39] Nevertheless, comparison of subgroups with and 
without upper limb impairment provides some evidence of validity: mean DASH scores 
between the two subsamples were significantly different implying that the DASH could 
discriminate between groups known to differ in level of upper limb function (Supplementary 
Tables I and II).  
 
One aim of our study was to compare and contrast two psychometric methods: CTT and 
RMT. CTT methods, based on weak measurement theory,[16, 29] are limited in their ability 
to provide detailed diagnostic item- and person-level examinations, and there is a lack of 
criteria against which to make judgements on scale and item performance. The existing 
arbitrary criteria of traditional methods are based on assumptions that cannot be tested 
formally.[29, 40] 
 
The added value of RMT is highlighted by the limitations identified: disordered response 
categories, item misfit and sub-optimal targeting. Importantly, RMT analyses provide the 
evidence-base for modifying and improving the DASH for future application in acute stroke 
research. Psychometric analysis plays a key role in scale development and testing: to ensure 
that scales provide scientifically robust, clinically meaningful and clinically interpretable 
measures. The sophisticated techniques of RMT can help to ensure that PRO instruments are 
robust measures of the health constructs they purport to quantify. 
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Table 1 Sample characteristics at baseline (n = 172) 
Variable Total 
Gender, % (n)  
Female 41 (71) 
Age, years  
Mean (SD) 61 (17) 
Range 18–93 
Time post-stroke, weeks   
Mean (SD) 3 (3) 
Range 1–12 
Handedness, % (n)  
Right 97 (166) 
Aphasia, % (n)  
Yes 8 (13) 
Upper limb impairment, % (n)  
Yes 58 (99) 
No 42 (73) 
Treatment group, % (n)  
HASU* 73 (125) 
ARU† 20 (34) 
NRU‡ 7 (13) 
*HASU = Hyper-acute Stroke Unit at the National Hospital for 
Neurology and Neurosurgery (NHNN); †ARU = Albany Rehabilitation 
Unit at the NHNN; ‡ NRU = National Rehabilitation Unit at the NHNN. 
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Table 2 Measurement characteristics: raw score metric (n=271) 
Measurement characteristic* Value                                 
Data completeness   
Item missing data, % 0 
Computable scale scores, % 100 
Scaling assumptions  
Item mean scores: range 1.59–3.15 
Item SD: range 0.78–1.49 
Item variance: range 0.60–2.22 
Corrected item-total correlations: range 0.55–0.95 
Targeting   
Mean score (SD) 36.0 (26.8) 
Possible score range† 0–100 
Observed score range 0–88 
Ceiling/floor effect, %‡ 14.4/0 
Skewness 0.03 
Reliability   
Cronbach’s alpha 0.99 
Mean inter-item correlation 0.70 
SEM§ 2.68 
95% CI|| ±5.25 
Responsiveness: Group level comparison (n=99)#  
Time 1 mean (SD) [range] 48.2 (24.3) [0 to 88] 
Time 2 mean (SD) [range] 35.8 (23.3) [0 to 85] 
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Change mean (SD) [range]** 12.4 (17.7) [−41.7 to +68.3] 
t-value (p) 7.01 (0.000) 
ES†† 0.51 
SRM‡‡ 0.70 
*Measurement characteristics based on raw scores; † High scores indicate greater disability; ‡ Ceiling effect = 
% scoring 0 (least impact on disability), floor effect = % scoring 100 (greatest impact on disability); § SEM, 
standard error of measurement = 𝑆𝐷√(1 − 𝑎𝑙𝑝ℎ𝑎); || 95% confidence interval around individual person scores 
= ±1.96 × 𝑆𝐸𝑀;  # Participants with upper limb impairments only, measured at baseline (Time 1) and 6 weeks 
(Time 2); ** Change = 𝑇𝑖𝑚𝑒 1 − 𝑇𝑖𝑚𝑒 2; †† ES, effect size = 𝑚𝑒𝑎𝑛 𝑐ℎ𝑎𝑛𝑔𝑒 𝑆𝐷 𝑇𝑖𝑚𝑒 1⁄ ; ‡‡ SRM, standardised 
response mean = 𝑚𝑒𝑎𝑛 𝑐ℎ𝑎𝑛𝑔𝑒 𝑆𝐷 𝑐ℎ𝑎𝑛𝑔𝑒⁄ . 
 
 
 
Table 3 Measurement characteristics: Rasch measurement metric (n=271) 
Measurement characteristic* Value                                 
Item locations  
 
Mean (SD) 0.00 (0.85) 
Range −1.61 to +1.78 
Thresholds  
Range −3.95 to +3.59 
Person measures  
Mean (SD) −1.59 (2.86) 
Range −6.65 to +2.90 
Reliability  
Person Separation Index †  0.96 
Responsiveness: Group level comparison (n=99)‡  
Time 1 mean (SD) [range] −0.36 (2.39) [−6.65 to +2.90] 
Time 2 mean (SD) [range] −1.28 (2.22) [−6.65 to +2.57] 
Change mean (SD) [range]§ 0.92 (1.85) [−4.66 to +5.49] 
t-value (p) 4.96 (0.000) 
ES|| 0.38 
SRM# 0.50 
Responsiveness:  Individual person level comparison (n=99)**  
Significant improvement, % (n) 51 (50) 
Non-significant improvement, % (n) 29 (29) 
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No change, % (n) 7 (7) 
Non-significant worsening, % (n) 6 (6) 
Significant worsening, % (n) 7 (7) 
*Measurement characteristics based on raw score transformation into linear measurements; † Person 
Separation Index (PSI), a reliability statistic analogous to Cronbach’s alpha; ‡ Participants with upper limb 
impairments only, measured at baseline (Time 1) and 6 weeks (Time 2); § Change = 𝑇𝑖𝑚𝑒 1 − 𝑇𝑖𝑚𝑒 2; || ES, 
effect size = 𝑚𝑒𝑎𝑛 𝑐ℎ𝑎𝑛𝑔𝑒 𝑆𝐷 𝑇𝑖𝑚𝑒 1⁄ ; # SRM, standardised response mean = 𝑚𝑒𝑎𝑛 𝑐ℎ𝑎𝑛𝑔𝑒 𝑆𝐷 𝑐ℎ𝑎𝑛𝑔𝑒⁄ ; ** 
Significant improvement = 𝑆𝑖𝑔𝐶ℎ𝑎𝑛𝑔𝑒 ≥ +1.96; Non-significant improvement = 0 < 𝑆𝑖𝑔𝐶ℎ𝑎𝑛𝑔𝑒 + 1.95; No 
change = 𝑆𝑖𝑔𝐶ℎ𝑎𝑛𝑔𝑒 = 0; Non-significant worsening = −1.95 < 𝑆𝑖𝑔𝐶ℎ𝑎𝑛𝑔𝑒 < 0; Significant worsening = 
𝑆𝑖𝑔𝐶ℎ𝑎𝑛𝑔𝑒 ≤ −1.96. Note: SigChange = 𝑐ℎ𝑎𝑛𝑔𝑒 𝑆𝐸𝐷⁄  where SED, standard error of the difference 
=√(𝑆𝐸 𝑇1)2 + (𝑆𝐸 𝑇2)2. 
 
 
 
Table 4 DASH: Item fit statistics ordered by location (n = 271) 
   Item locations  Item fit indicators 
Item Label 
Threshold 
ordering 
Estimate 
Standard 
Error 
 
Fit 
Residual 
Chi-square 
value 
19 Recreational activities: move arm        -1.61 0.10  -1.19 3.58 
18 Recreational activities: force/impact       -1.45 0.10  -1.42 3.03 
12 Change lightbulb           -0.97 0.10  -4.40 8.19 
8 Garden                      -0.89 0.10  -5.32 13.96 
11 Carry heavy object  -0.81 0.10  -4.14 8.41 
7 Do heavy chores                -0.75 0.10  -5.23 10.63 
30 Feeling less capable         -0.59 0.10  12.39 95.96 
10 Carry shopping bag                  -0.45 0.09  -2.24 8.07 
1 Open new jar   -0.39 0.10  -4.65 18.69 
9 Make bed                    -0.35 0.10  -4.86 18.29 
23 Limited in work/daily activities           -0.35 0.10  -0.37 2.55 
4 Prepare meal                -0.34 0.10  -4.75 17.70 
17 Recreational activities: little effort       -0.27 0.10  -4.62 19.57 
6 Place object on shelf             -0.20 0.10  -4.93 15.93 
22 Interference with social activities          -0.16 0.09  0.97 2.90 
5 Push open heavy door                   -0.15 0.10  -3.57 11.18 
20 Manage transportation needs       -0.13 0.09  -0.98 11.10 
13 Wash hair                  0.01 0.10  -3.95 17.83 
27 Weakness in arm, shoulder, hand                                  0.06 0.10  -1.31 5.95 
14 Wash back                  0.16 0.10  -2.33 14.75 
3 Turn key                    0.27 0.09  2.20 11.34 
16 Use knife to cut food                   0.30 0.10  -2.36 11.99 
21 Sexual activities          0.35 0.08  6.61 30.81 
15 Put on sweater             0.58 0.10  -2.99 12.41 
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2 Write                      × 0.89 0.08  4.55 153.36 
28 Stiffness in arm, shoulder, hand                            1.15 0.10  2.17 16.20 
25 Pain performing an activity    × 1.35 0.10  0.91 48.99 
24 Pain in arm, shoulder, hand                      × 1.43 0.10  0.92 44.23 
26 Tingling in arm, shoulder, hand                 × 1.53 0.10  2.59 53.42 
29 Difficulty sleeping               1.78 0.11  1.74 9.80 
Bold highlighted values indicate items falling outside recommended limits (fit residual −2.5 to +2.5) or value 
statistically significant (chi-square). 
 
 
 
 
Figure 1. Targeting of the sample to DASH items. 
1A: This figure shows the distribution of person measurements (upper histogram) against the 
distribution of item locations (lower histogram). People (upper histogram) are located along 
the continuum from more ability (left hand bars) to less ability (right hand bars). Items (lower 
histogram) are located relative to each other: the easiest items (requiring less ability to 
perform) represented by the bars on the right and the most difficult items (requiring more 
ability to perform) represented by the bars on the left. People located outside the scale’s 
measurement range (−2 to +2 logits) indicate suboptimal scale-to-sample targeting. 
 
1B: This figure shows the distribution of person measurements (upper histogram) against the 
distribution of the item threshold locations (lower histogram). The lower histogram shows the 
distribution of item thresholds which represent the boundaries between adjacent response 
categories. A threshold is the point on the continuum at which a response in either of two 
adjacent categories is equally likely. The DASH items have five response categories, so there 
 25 
 
are four boundaries or thresholds for each item. The item location (lower histogram in Figure 
1A) is the mean of the four threshold locations.  
 
 
 
 
 
 
 
